Hangzhou Biotest Biotech Co.,Ltd.
SSE:688767.SS
32.14 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 559.402 | 442.11 | 1,901.144 | 1,818.076 | 865.371 | 208.842 | 180.301 | 121.771 |
| Cost of Revenue
| 263.801 | 269.596 | 884.777 | 693.939 | 218.184 | 119.517 | 110.967 | 75.045 |
| Gross Profit
| 295.601 | 172.515 | 1,016.367 | 1,124.137 | 647.187 | 89.325 | 69.334 | 46.726 |
| Gross Profit Ratio
| 0.528 | 0.39 | 0.535 | 0.618 | 0.748 | 0.428 | 0.385 | 0.384 |
| Reseach & Development Expenses
| 63.575 | 80.475 | 108.209 | 61.925 | 41.324 | 16.845 | 9.667 | 10.852 |
| General & Administrative Expenses
| 24.097 | 20.434 | 25.461 | 19.917 | 9.403 | 10.197 | 7.361 | 7.207 |
| Selling & Marketing Expenses
| 12.224 | 11.049 | 28.466 | 22.913 | 38.476 | 18.544 | 16.017 | 13.161 |
| SG&A
| 36.321 | 31.482 | 53.927 | 42.829 | 47.879 | 28.741 | 23.377 | 20.368 |
| Other Expenses
| 2.3 | -56.267 | 34.165 | 37.299 | 19.862 | 8.613 | -0.013 | 0.015 |
| Operating Expenses
| 102.195 | 55.691 | 196.301 | 142.053 | 109.066 | 54.199 | 41.704 | 35.453 |
| Operating Income
| 193.406 | 116.824 | 914.343 | 966.523 | 513.083 | 32.231 | 22.547 | 4.261 |
| Operating Income Ratio
| 0.346 | 0.264 | 0.481 | 0.532 | 0.593 | 0.154 | 0.125 | 0.035 |
| Total Other Income Expenses Net
| 1.513 | -0.947 | -12.446 | 2.105 | 1.243 | 0.037 | -0.013 | 0.015 |
| Income Before Tax
| 194.919 | 115.877 | 901.897 | 968.628 | 514.326 | 32.268 | 22.534 | 4.276 |
| Income Before Tax Ratio
| 0.348 | 0.262 | 0.474 | 0.533 | 0.594 | 0.155 | 0.125 | 0.035 |
| Income Tax Expense
| 28.144 | 10.577 | 128.313 | 132.872 | 79.359 | 4.333 | 3.681 | 0.921 |
| Net Income
| 169.515 | 106.606 | 773.634 | 833.591 | 435.147 | 28.228 | 18.907 | 4.031 |
| Net Income Ratio
| 0.303 | 0.241 | 0.407 | 0.459 | 0.503 | 0.135 | 0.105 | 0.033 |
| EPS
| 1.61 | 1 | 7.25 | 7.81 | 4.08 | 0.26 | 0.24 | 0.05 |
| EPS Diluted
| 1.61 | 1 | 7.25 | 7.81 | 4.08 | 0.26 | 0.24 | 0.05 |
| EBITDA
| 217.564 | 146.453 | 926.414 | 980.618 | 520.918 | 38.411 | 27.659 | 8.268 |
| EBITDA Ratio
| 0.389 | 0.331 | 0.487 | 0.539 | 0.602 | 0.184 | 0.153 | 0.068 |